Overview

A Study of Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if it is safe and effective to give efavirenz plus stavudine plus lamivudine to patients who have never taken anti-HIV drugs.
Phase:
Phase 2
Details
Lead Sponsor:
Dupont Merck
Treatments:
Efavirenz
Lamivudine
Stavudine